Not approved (research only)Semax analogCognitive research
Adamax
Adamax is a vendor-marketed analog of the Russian peptide Semax; we found no peer-reviewed study of a compound by this name.
What is Adamax?
Adamax is a vendor-marketed analog of the Russian peptide Semax; we found no peer-reviewed study of a compound by this name. Adamax is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Key takeaways
- Adamax is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
- PubMed indexes 39 papers on Adamax (0 tagged as clinical trials) as of October 19, 2026.
- 18 vendors in our directory listed Adamax in their public catalog on October 19, 2026.
Regulatory & access status
Adamax is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on Adamax?
PubMed indexes 39 papers mentioning Adamax in the title or abstract, 35 of them from the last five years and 0 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Enhancing accuracy in brain stroke detection: Multi-layer perceptron with Adadelta, RMSProp and AdaMax optimizers. — Front Bioeng Biotechnol, 2023
- Mine Gas Concentration Forecasting Model Based on an Optimized BiGRU Network. — ACS Omega, 2020
- Indoor surface classification for mobile robots. — PeerJ Comput Sci, 2024
- Effective skin cancer classification by modified and optimized inception-ResNet-V2 model. — Sci Rep, 2025
- Optimizing home energy management: Robust and efficient solutions powered by attention networks. — Heliyon, 2024
- A two-stage renal disease classification based on transfer learning with hyperparameters optimization. — Front Med (Lausanne), 2023
What the evidence does not show
- Paper counts measure research attention, not whether Adamax works or is safe.
- No clinical trial in humans is tagged in PubMed under this name.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Research suppliers that list Adamax
18 vendors in our directory listed a product matching Adamax in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
- Atomik Labz
- Backroad Aminos
- Biocollex Research
- Bulk Peptide Supply
- Eros Peptides
- Evolve BioPep
- Ion Peptide
- Liberty Peptides
- Licensed Peptides
- Peptide Crafters
- Plum Labs Research
- ProtideHealth
- Pure Lab Peptides
- Ramp Peptides
- San Diego Peptides
- Science.bio
- Southern Aminos
- Sunrise BioResearch
Prices per mg, where we could verify them, are on our price comparison.
Adamax reconstitution math
Lab arithmetic only, not dosing guidance: vial-by-vial concentration tables are on Adamax 5 mg vial math.
Adamax FAQ
Is Adamax FDA-approved?
Adamax is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Is Adamax safe?
There are no published human safety trials of Adamax that we could find. Products sold as "research use only" have no FDA review of purity, sterility or dose, and are not for human use.
How much research is there on Adamax?
PubMed indexes 39 papers on Adamax (0 tagged as clinical trials) as of October 19, 2026.
Who sells Adamax?
Atomik Labz, Backroad Aminos, Biocollex Research, Bulk Peptide Supply, Eros Peptides, Evolve BioPep and 12 more listed it on their public catalogs when we checked; a listing is not an endorsement.
Related compounds
OxytocinVIPCerebrolysinDSIPSemaxSelankDihexaPinealonAll cognitive, neuro & sleep